Establishes "Remote Methadone Dosing Pilot Program;" appropriates $225,000.
Impact
The bill appropriates $225,000 from the General Fund to facilitate the program's implementation. This funding includes grants of $75,000 for each OTP selected to participate in the pilot program, which will take place over a three-year period. Specific sites for participation include OTPs in Atlantic City, Camden, and Paterson. Each participating program is mandated to report patient outcomes and cost data back to the Department of Human Services annually. This provision heralds an opportunity to analyze data on treatment compliance, retention, and potential cost reductions, including savings on medical transportation.
Summary
Assembly Bill A2191 establishes a Remote Methadone Dosing Pilot Program under the Department of Human Services in New Jersey. The aim of this program is to enhance compliance and reduce costs related to medication-assisted treatments provided by opioid treatment programs (OTPs) through remote dosing methods. By implementing telehealth and telemedicine services for monitoring patients, the bill intends to evaluate the efficacy of remote methadone dosing on patient outcomes and overall treatment costs for opioid use disorder. It also emphasizes the need for legislative recommendations following the evaluation of the pilot program's effectiveness after a stipulated period.
Contention
Despite the program's benefits, there are concerns regarding its implementation. The legislation explicitly states that participation is voluntary for patients, addressing potential issues of coercion in treatment. However, discussions around the bill may highlight the apprehensions of stakeholders in the mental health and addiction services sectors regarding the long-term implications of remote dosing on patient relationships with healthcare providers. There is also an underlying apprehension about patient trust in remote monitoring technologies, which may affect the willingness of some patients to engage with the program despite its convenience and potential benefits.
Health: pharmaceuticals; delivery of prescription drugs associated with medically assisted treatment programs in county jails; allow. Amends sec. 17745a of 1978 PA 368 (MCL 333.17745a).
Health: substance use disorder treatment; substance use disorder services programs requirements; modify, and prohibit the promulgation of certain rules. Amends secs. 6230 & 6234 of 1978 PA 368 (MCL 333.6230 & 333.6234).
Modifying administrative rules relating to regulation of opioid treatment programs and requiring adjustments to the rates for substance use disorder treatment services with medications for opioid use disorder. (FE)
Modifying administrative rules relating to regulation of opioid treatment programs and requiring adjustments to the rates for substance use disorder treatment services with medications for opioid use disorder. (FE)